Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 40 and up

Boosting Smell Training in Adults with HIV

Official title: A Feasibility and Acceptability Study Testing Two Types of Smell Exposure Interventions in Middle-Aged Older Adults With HIV

Run by University of Alabama at Birmingham · NCT07221123 · Data updated 2026-11-12

This study tests two at-home smell-training methods to see if they improve scent function and thinking skills in adults with HIV.

Quick facts

PhasePhase 2
Study typeInterventional
Ages40 Years and up
SexAll
Enrollment80 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Birmingham, Alabama)
StatusRecruiting
StartedMay 2, 2026
Main results expectedJuly 1, 2027
Study endsDecember 31, 2027
Registry record updatedJune 11, 2026
Trial IDNCT07221123 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40 or older with HIV and self-reported cognitive complaints, who are proficient in English and able to attend in-person visits within 60 miles of the center.

Probably not a fit

Participants with recent nasal infections, significant neuro-comorbidities, or other exclusion criteria may not benefit from the training.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 2 trial compares conventional at-home olfactory training with a scented marker training approach over 8 weeks in adults living with HIV. Participants are randomized to one of the two interventions after a baseline assessment, then return for a post-intervention evaluation of olfactory and cognitive performance. The study uses a two-group pre-post design and stratified randomization by gender and smoking status to control for potential confounders. Recruitment is from the UAB 1917 HIV/AIDS Clinic, with in-person baseline and posttest visits and customary follow-up procedures. The primary goals are to assess feasibility and acceptability as well as any improvements in olfactory and cognitive function.

Why it matters

Potential benefit: If successful, participants could experience improved sense of smell and related cognitive benefits from the training.

How similar studies have gone: Prior olfactory training studies suggest potential sensory benefits, but this specific HIV-focused, home-based, two-arm approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants (men \& women) must be 40+ years
* have cognitive complaints.
* must be proficient in English

Exclusion Criteria:

* a sinus infection (within the past 3 months), thrush, candidiasis, pregnant, current cold or flu, hay fever, asthma, nasal allergies, opportunistic infections (including COVID-19) within the past 3 months, or current nasal obstruction condition.
* Participation requires \~8 weeks and in-person visits, participants living beyond 60 miles away from the center will be excluded.
* Participants living in unstable housing (e.g., shelter) or with significant neuro-comorbidities (e.g., schizophrenia) will be excluded.
* Other conditions (e.g., legally blind/deaf, currently undergoing radiation or chemotherapy, or a history of significant brain trauma) that could impact olfactory and cognitive testing also necessitate exclusion.

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.